About 50 Mg Eltrombopag Tablets
Experience a deal on Fresh 50 mg Eltrombopag Tablets designed for ace performance in the management of chronic immune thrombocytopenic purpura (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. These first-string, polished film-coated tablets feature a robust 50 mg strength per dose, packed in secure blister packs or boxes-ideal for reliable, once-daily oral use. Marketed globally, and suitable for both adults and selected children under strict medical guidance, they offer high bioavailability for maximum benefit. Ensure all purchases are prescription-based and consult your physician regarding any specific health concerns or possible contraindications.
Application & Advanced Features
50 Mg Eltrombopag Tablets are expertly formulated for oral administration, showcasing a polished surface and consistently robust tablet texture. Their application centers on treating thrombocytopenia due to ITP, hepatitis C, or severe aplastic anemia. Key product features include high bioavailability, film coating for surface integrity, and once-daily dosing convenience. These ace tablets are supplied to hospitals, clinics, and specialty pharmacies by trusted distributors, ensuring first-string quality from manufacturing to point-of-use.
Sample Policy, Delivery & Export Markets
Ordering samples of 50 Mg Eltrombopag Tablets is streamlined through transparent packaging protocols and clear sample policies. Order processing is efficient, with careful packing and dispatch ensuring the medication's safety and integrity. Typical delivery times are prompt, suitable for international demand. The main export markets include Asia, Africa, the Middle East, and beyond. Every box is securely packaged to maintain product freshness throughout its shelf life, supporting global healthcare distribution standards.
FAQ's of 50 Mg Eltrombopag Tablets:
Q: How should 50 Mg Eltrombopag Tablets be administered for best results?
A: These tablets should be taken orally as directed by your physician, typically once daily. It is advisable to avoid antacids within 4 hours of dosing and to strictly follow dosage guidelines for optimal benefits.
Q: What are the main indications for prescribing Eltrombopag 50 mg tablets?
A: Eltrombopag is primarily indicated for treating thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura, hepatitis C-associated thrombocytopenia, and severe aplastic anemia.
Q: When can I expect delivery after placing a purchase order for Eltrombopag tablets?
A: Delivery times vary depending on the distributor and destination, but careful order processing and reliable packaging usually result in timely dispatch and prompt receipt, especially for bulk export orders.
Q: Where are your main export markets for 50 Mg Eltrombopag Tablets?
A: Our main export markets include India, as well as other countries in Asia, Africa, and the Middle East, with established supply chains to distributors, exporters, and healthcare providers.
Q: What precautions should be taken during the use of Eltrombopag tablets?
A: Patients must be monitored regularly for liver function and platelet counts. It is essential to take this medication only under medical supervision, especially in individuals with any hepatic impairment.
Q: What are the storage instructions for maintaining tablet potency and freshness?
A: Tablets should be stored below 30C, protected from light and moisture, to preserve their quality and effectiveness throughout their 24-month shelf life.